695037563	695037563	CD	B-NP	O
|	|	NN	I-NP	O
VUOC	VUOC	NN	I-NP	O
|	|	NN	I-NP	O
22874446	22874446	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5277719	5277719	CD	B-NP	O
|	|	CC	I-NP	O
6/25/2003	6/25/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
VOLUME	VOLUME	NNP	I-NP	I-protein
OVERLOAD	OVERLOAD	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/25/2003	6/25/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/2003	11/22/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
JONAS	JONAS	NNP	B-NP	O
STARNS	STARNS	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Discharge	Discharge	NNP	I-NP	O
date	date	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
ASSOCIATED	ASSOCIATED	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
33	33	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
etiology	etiology	NN	B-NP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dyslipidemia	Dyslipidemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Gastritis	Gastritis	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
increasing	increase	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
prescribed	prescribe	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
inconvenience	inconvenience	NN	I-NP	O
of	of	IN	B-PP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
frequently	frequently	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
feeling	feel	VBG	I-VP	O
overwhelmed	overwhelmed	JJ	B-ADJP	O
by	by	IN	B-PP	O
so	so	RB	B-NP	O
many	many	JJ	I-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
feeling	feel	VBG	I-VP	O
better	well	RBR	B-ADVP	O
with	with	IN	B-PP	O
improved	improve	VBN	B-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Deep	Deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
PE	PE	NN	B-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2003	2003	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
nephrotic	nephrotic	JJ	B-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Iron	Iron	NNP	B-NP	O
and	and	CC	O	O
folate	folate	VB	B-VP	O
deficiency	deficiency	NN	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Paroxysmal	Paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Nonsustained	Nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Cholesterol	Cholesterol	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
knee	knee	NN	I-NP	O
and	and	CC	O	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Arthroscopic	Arthroscopic	JJ	B-NP	O
knee	knee	NN	I-NP	O
surgery	surgery	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Gastritis	Gastritis	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Benign	Benign	JJ	B-NP	O
colon	colon	NN	I-NP	O
polyps	polyp	NNS	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
10	10	CD	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Cataracts	Cataract	NNS	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Glaucoma	Glaucoma	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
120	120	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	B-protein
sulfate	sulfate	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Folate	Folate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.d.	q.d.	IN	B-PP	I-protein
5	5	CD	B-NP	I-protein
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.d.	q.d.	RB	B-ADVP	I-protein
6	6	CD	B-NP	I-protein
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Multivitamins	Multivitamin	NNS	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Accupril	Accupril	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Avandia	Avandia	NNP	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
SOCIAL	SOCIAL	NNP	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
3-packs-per-day	3-packs-per-day	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-cell_line
97.3	97.3	CD	I-NP	I-cell_line
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
143/70	143/70	CD	I-NP	I-DNA
,	,	,	O	O
pulse	pulse	NN	B-NP	O
57	57	CD	I-NP	O
,	,	,	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Sclerae	Sclerae	NNP	B-NP	O
anicteric	anicteric	JJ	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
14	14	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Crackles	Crackles	NNP	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
,	,	,	O	O
half	half	DT	B-NP	O
way	way	NN	I-NP	O
up	up	IN	B-PP	O
both	both	DT	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
decreased	decrease	VBN	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sound	sound	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
areas	area	NNS	B-NP	O
of	of	IN	B-PP	O
erythematous	erythematous	JJ	B-NP	O
and	and	CC	I-NP	O
shiny	shiny	JJ	I-NP	O
shallow	shallow	NN	I-NP	O
ulcerations	ulceration	NNS	I-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
euthymic	euthymic	JJ	B-ADJP	O
without	without	IN	B-PP	O
focal	focal	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
147	147	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
110	110	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
23	23	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
69	69	CD	I-NP	I-protein
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
6.7	6.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39.4	39.4	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
258	258	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
432	432	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
and	and	CC	I-NP	O
D-dimer	D-dimer	NN	I-NP	B-protein
was	be	VBD	B-VP	O
50	50	CD	B-NP	O
and	and	CC	I-NP	O
69	69	CD	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
lung	lung	NN	I-NP	O
volumes	volume	NNS	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
59	59	CD	B-NP	O
,	,	,	O	O
axis	axis	NN	B-NP	O
of	of	IN	B-PP	O
-36	-36	CD	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
likely	likely	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
regarding	regard	VBG	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
subacute	subacute	JJ	I-NP	O
silent	silent	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
given	give	VBN	B-VP	O
new	new	JJ	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
statin	statin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
troponins	troponin	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low-dose	low-dose	JJ	I-NP	B-protein
short-acting	short-acting	JJ	I-NP	I-protein
beta-blocker	beta-blocker	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
Lopressor	Lopressor	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
switched	switch	VBN	B-VP	O
to	to	TO	B-VP	O
captopril	captopril	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
short-acting	short-acting	JJ	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
perfusion	perfusion	NN	B-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
echo	echo	NN	B-NP	O
showed	show	VBD	B-VP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
telemetry	telemetry	NN	I-NP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
beats	beat	NNS	I-NP	O
of	of	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
carefully	carefully	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	I-VP	O
repleted	replete	VBN	I-VP	O
as	as	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
depressed	depressed	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
frank	frank	NN	I-NP	O
fluid	fluid	NN	I-NP	O
overload	overload	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
JVP	JVP	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
-2	-2	CD	I-NP	O
liters	liter	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
t.i.d.	t.i.d.	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
carefully	carefully	RB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
increase	increase	NN	B-NP	O
on	on	IN	B-PP	O
11/26/03	11/26/03	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
hold	hold	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
diuresed	diurese	VBD	B-VP	O
about	about	RB	B-NP	O
3	3	CD	I-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
liters	liter	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
until	until	IN	B-PP	O
7/7/03	7/7/03	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
very	very	RB	B-ADJP	O
close	close	RB	I-ADJP	O
to	to	TO	B-PP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
echo	echo	JJ	I-NP	O
findings	finding	NNS	I-NP	O
with	with	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
and	and	CC	O	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
wish	wish	VB	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
investigation	investigation	NN	I-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
other	other	JJ	I-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
an	an	DT	B-NP	O
ANA	ANA	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
studies	study	NNS	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
iron	iron	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
thiamine	thiamine	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
close	close	JJ	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
careful	careful	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
balance	balance	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
initially	initially	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
DVT	DVT	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
dimer	dimer	NN	I-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
initial	initial	JJ	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
emboli	embolus	NNS	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
further	far	JJR	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
spiral	spiral	JJ	B-NP	O
chest	chest	NN	I-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
folate	folate	NN	I-NP	O
and	and	CC	I-NP	O
iron-deficiency	iron-deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
folate	folate	NN	B-NP	O
and	and	CC	I-NP	O
iron	iron	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
20	20	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
known	known	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Avandia	Avandia	NNP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	I-VP	O
it	it	PRP	B-NP	O
contraindication	contraindication	NN	B-NP	O
in	in	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
about	about	IN	B-NP	O
0.8	0.8	CD	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_type
urine	urine	NN	I-NP	I-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
and	and	CC	O	O
sediment	sediment	NN	B-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
frank	frank	NN	B-NP	O
proteinuria	proteinuria	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
known	known	JJ	I-NP	O
nephrotic	nephrotic	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1.5	1.5	CD	I-NP	O
to	to	TO	I-NP	O
1.6	1.6	CD	I-NP	O
range	range	NN	I-NP	O
until	until	IN	B-PP	O
11/26/03	11/26/03	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
bumped	bump	VBD	B-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
and	and	CC	O	O
kept	keep	VBD	B-VP	O
rising	rise	VBG	I-VP	O
until	until	IN	B-PP	O
1/28/03	1/28/03	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
reached	reach	VBD	B-VP	O
2.7	2.7	CD	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
urine	urine	NN	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	B-cell_type
eosinophils	eosinophil	NNS	I-NP	I-cell_type
and	and	CC	O	O
sediment	sediment	NN	B-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
intravascular	intravascular	JJ	B-NP	O
volume	volume	NN	I-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

Diuresis	Diuresis	NN	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
hold	hold	NN	B-NP	O
on	on	IN	B-PP	O
11/2/03	11/2/03	CD	B-NP	O
and	and	CC	I-NP	O
10/10/03	10/10/03	CD	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
halfed	halfe	VBN	I-VP	O
on	on	IN	B-PP	O
10/10/03	10/10/03	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
chemistries	chemistry	NNS	I-NP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
resolves	resolve	VBZ	B-VP	O
,	,	,	O	O
to	to	TO	B-VP	O
resume	resume	VB	I-VP	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
UTI	UTI	NNP	I-NP	O
with	with	IN	B-PP	O
E.	E.	NNP	B-NP	O
Coli	Coli	NNP	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Bactrim	Bactrim	NN	B-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
.	.	.	O	O

Rheumatological	Rheumatological	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
arthritis	arthritis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Celebrex	Celebrex	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
propensity	propensity	NN	I-NP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
fluid	fluid	NN	B-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
joint	joint	JJ	I-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
swollen	swell	VBN	I-VP	O
PIP	PIP	NN	B-NP	O
joints	joint	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
hands	hand	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
marked	marked	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
over	over	IN	B-PP	O
both	both	DT	B-NP	O
wrists	wrist	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
that	that	WDT	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
oxycodone	oxycodone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
resolves	resolve	VBZ	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Celebrex	Celebrex	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
antiinflammatory	antiinflammatory	JJ	I-NP	O
medications	medication	NNS	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
effected	effect	VBN	I-ADJP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

ANA	ANA	NN	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Psyche	Psyche	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Celexa	Celexa	NN	B-NP	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
service	service	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
on	on	IN	B-PP	O
1/28/03	1/28/03	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	B-protein
sulfate	sulfate	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Prozac	Prozac	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Folate	Folate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
11/2/03	11/2/03	CD	B-NP	O
and	and	CC	I-NP	O
1/28/03	1/28/03	CD	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
until	until	IN	B-SBAR	O
creatinine	creatinine	NN	B-NP	O
increases	increase	NNS	I-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
once	once	RB	B-ADVP	O
symptoms	symptom	NNS	B-NP	O
and	and	CC	O	O
sign	sign	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
occur	occur	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
human	human	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	I-protein
q.p.m.	q.p.m.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
11/2/03	11/2/03	CD	B-NP	O
and	and	CC	I-NP	O
1/28/03	1/28/03	CD	I-NP	O
given	give	VBN	B-PP	O
increasing	increase	VBG	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
until	until	IN	B-SBAR	O
creatinine	creatinine	NN	B-NP	O
decreases	decrease	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Multivitamins	Multivitamin	NNS	B-NP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Bactrim	Bactrim	RB	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Prednisolone	Prednisolone	NN	B-NP	O
acetate	acetate	NN	I-NP	O
0.125	0.125	CD	B-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
OU	OU	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
for	for	IN	B-PP	O
known	known	JJ	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
needs	need	VBZ	B-VP	O
monitoring	monitor	VBG	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
updated	update	VBN	I-VP	O
with	with	IN	B-PP	O
medications	medication	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-8447024	2-8447024	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WINDOVER	WINDOVER	NNP	B-NP	O
,	,	,	O	O
COURTNEY	COURTNEY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FLOCKHART	FLOCKHART	NNP	B-NP	O
,	,	,	O	O
JAKE	JAKE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9719748	9719748	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/28/03	1/28/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/28/03	1/28/03	CD	B-NP	O

